T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.01B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$554M |
| 3 |
Canadian Natural Resources
CNQ
|
+$543M |
| 4 |
Goldman Sachs
GS
|
+$528M |
| 5 |
CAVA Group
CAVA
|
+$522M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$735M |
| 2 |
Microsoft
MSFT
|
+$612M |
| 3 |
TransUnion
TRU
|
+$601M |
| 4 |
Fortinet
FTNT
|
+$514M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.09% |
| 2 | Healthcare | 22.65% |
| 3 | Consumer Discretionary | 12.39% |
| 4 | Financials | 11.97% |
| 5 | Industrials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFXT
526
Enerflex
EFXT
$2.62B
| $5.9M | ﹤0.01% |
864,847
-3,901
| -0.4% | -$23.7K |
|
|
ELME
527
Elme Communities
ELME
$144M
| $5.89M | ﹤0.01% |
358,321
-2,427,650
| -87% | -$40.1M |
|
528
Huntsman Corp
HUN
$1.78B
| $5.76M | ﹤0.01% |
+213,195
| New | +$5.54M |
|
529
West Fraser Timber
WFG
$5.5B
| $5.64M | ﹤0.01% |
+65,539
| New | +$4.95M |
|
530
Seer Inc
SEER
$118M
| $5.55M | ﹤0.01% |
1,299,785
| – | – |
|
531
Jack in the Box
JACK
$358M
| $5.53M | ﹤0.01% |
+56,740
| New | +$5.16M |
|
532
Crane Co
CR
$12.9B
| $5.01M | ﹤0.01% |
+56,226
| New | +$4.34M |
|
533
Winmark
WINA
$1.24B
| $4.82M | ﹤0.01% |
14,493
-94,965
| -87% | -$32.2M |
|
534
RenaissanceRe
RNR
$13.2B
| $4.74M | ﹤0.01% |
+25,408
| New | +$5.06M |
|
535
Burke & Herbert Financial Services Corp
BHRB
$1.49B
| $4.67M | ﹤0.01% |
+72,778
| New | +$5.71M |
|
|
EB
536
DELISTED
Eventbrite
EB
| $4.66M | ﹤0.01% |
487,395
+32,858
| +7% | +$258K |
|
537
Douglas Emmett
DEI
$1.95B
| $4.45M | ﹤0.01% |
353,644
-635,119
| -64% | -$7.67M |
|
538
Saga Communications
SGA
$64.6M
| $4.42M | ﹤0.01% |
207,024
-147,846
| -42% | -$3.17M |
|
|
VZIO
539
DELISTED
VIZIO Holding Corp.
VZIO
| $1.5M | ﹤0.01% |
221,691
-476,927
| -68% | -$3.69M |
|
540
Oxford Industries
OXM
$538M
| $1.46M | ﹤0.01% |
14,795
-13,986
| -49% | -$1.43M |
|
541
PepsiCo
PEP
$189B
| $646K | ﹤0.01% |
+3,484
| New | +$650K |
|
542
Hydrofarm Holdings
HYFM
$8M
| $604K | ﹤0.01% |
77,347
| – | – |
|
543
McDonald's
MCD
$195B
| $549K | ﹤0.01% |
+1,839
| New | +$534K |
|
544
Abbott
ABT
$192B
| $541K | ﹤0.01% |
+4,955
| New | +$528K |
|
545
NextEra Energy
NEE
$179B
| $505K | ﹤0.01% |
+6,803
| New | +$515K |
|
546
Fate Therapeutics
FATE
$317M
| $500K | ﹤0.01% |
104,938
+4,858
| +5% | +$26.8K |
|
547
Accenture
ACN
$110B
| $420K | ﹤0.01% |
+1,361
| New | +$395K |
|
548
American Tower
AMT
$79.4B
| $411K | ﹤0.01% |
+2,115
| New | +$413K |
|
549
RTX Corp
RTX
$300B
| $404K | ﹤0.01% |
+4,122
| New | +$404K |
|
550
Costco
COST
$421B
| $387K | ﹤0.01% |
+718
| New | +$363K |
|
Similar funds
T. Rowe Price Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Investment Management held 596 positions worth $147B, up 5.3% from $139B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q2 2023 filing shows 53 new, 243 increased, 259 reduced and 30 closed positions. Its largest new stake was Biogen: 3,399,070 shares worth $968M. The largest sale was PNC Financial Services, an estimated $735M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q2 2023 buy was Biogen: 3,399,070 shares worth $968M.
- T. Rowe Price Investment Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $554M increase.
- T. Rowe Price Investment Management's biggest Q2 2023 reduction was PNC Financial Services, cutting an estimated $735M.
- T. Rowe Price Investment Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023, selling an estimated $331M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $147B portfolio in Q2 2023.
- T. Rowe Price Investment Management opened 53 new positions and closed 30 in Q2 2023.
- T. Rowe Price Investment Management's portfolio value rose 5.3% quarter-over-quarter to $147B.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.